All products
Vaccines
VaxiShield Yellow Fever
Live attenuated yellow fever vaccine for travellers and endemic regions
Overview
A single-dose live attenuated yellow fever vaccine indicated for active immunisation against yellow fever virus in adults and children from 9 months of age.
Key highlights
- Single primary dose
- Long-lasting protection
- Cold-chain 2–8°C
- WHO-prequalified reference strain
Indications
- Yellow fever prevention
- International travel requirement
- Endemic-area immunisation
This product page is intended for informational purposes. Full prescribing information is available to licensed healthcare professionals on request.